|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02348 DAWNRAYS PHARMA
Nominal 
0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 8.937% | 10.212% | 11.474% | 9.424% | 9.915% |
| ROAE (%) | 11.862% | 14.258% | 15.740% | 12.780% | 12.944% |
| Return on Capital Employed (%) | 11.037% | 13.065% | 13.555% | 11.062% | 11.787% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 55.729% | 60.543% | 58.470% | 53.760% | 56.407% |
| EBITDA Margin (%) | 44.646% | 42.868% | 44.982% | 38.450% | 38.691% |
| Pre-tax Profit Margin (%) | 35.969% | 34.313% | 37.705% | 32.345% | 33.062% |
| Net Profit Margin (%) | 28.320% | 28.024% | 30.741% | 26.178% | 26.887% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 2.572 X | 1.871 X | 2.168 X | 3.227 X | 2.769 X |
| Quick Ratio (X) | 2.256 X | 1.612 X | 1.876 X | 2.714 X | 2.478 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 21.074% | 27.849% | 28.198% | 24.801% | 27.278% |
| Total Debt / Total Assets (%) | 3.327% | 0.229% | 0.704% | 0.102% | 7.884% |
| Net Debt / Total Assets (%) | -21.677% | -21.872% | -16.596% | -25.072% | -9.036% |
| Total Debt / Shareholders' Funds (%) | 4.222% | 0.318% | 0.988% | 0.136% | 10.845% |
| Long Term Debt / Shareholders' Funds (%) | 0.004% | 0.017% | 0.064% | 0.093% | 0.140% |
| Net Debt / Shareholders' Funds (%) | -27.509% | -30.404% | -23.280% | -33.542% | -12.430% |
| Net Cash / (Debt) ($) | 785.299M | 803.270M | 554.224M | 728.037M | 251.778M |
| Net Cash / (Debt) per share ($) | 0.523 | 0.536 | 0.370 | 0.481 | 0.162 |
| Total Debt / Capital Employed (%) | 4.081% | 0.307% | 0.890% | 0.122% | 10.137% |
| Interest Coverage Ratio (X) | 419.662 X | 1182.693 X | 686.371 X | 69.620 X | 60.163 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 162.169 Day | 161.174 Day | 169.530 Day | 164.452 Day | 144.895 Day |
| Receivables Turnover (Day) | 114.915 Day | 107.074 Day | 106.122 Day | 125.033 Day | 137.891 Day |
| Payables Turnover (Day) | 61.233 Day | 52.462 Day | 47.119 Day | 56.014 Day | 55.169 Day |
| Remarks: | Real time quote last updated: 25/11/2024 07:45 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 493,046,000 |
| %Change | 92.640% |
| EPS / (LPS) | RMB 0.329 |
| NBV Per Share (¥) | RMB 2.178 |